NewsPublic figure
What Mario Lemieux's Story Can Teach Us About Hodgkin Lymphoma
The hockey legend was diagnosed with Hodgkin lymphoma in 1993 and returned to the ice after treatment. Here is what that diagnosis really means, explained simply.
A plain-language summary based on public reporting and trusted sources, linked below.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
Seven weeks, a press conference, and a game in Philadelphia
On January 12, 1993, Mario Lemieux told reporters he had Hodgkin lymphoma. He was 27 and leading the National Hockey League in scoring. His foundation's own account says the cancer was found after an enlarged lymph node was taken out of his neck.
He had radiation therapy. NHL.com reports that he returned to the ice on March 2, 1993, roughly seven weeks after the announcement, and played against the Philadelphia Flyers. His foundation says he flew to that game on the day of his final radiation session. He scored a goal and added an assist. He founded the Mario Lemieux Foundation the same year.
Those are the facts he and his foundation made public. Nothing here says what treatment should look like for anyone else. What follows is the medicine.
The cell that defines the disease
Lymphoma is cancer that starts in the lymph system, which is part of the immune defense network. Doctors sort lymphoma into two families, and Hodgkin lymphoma is the smaller one.
For 2026 the American Cancer Society projects about 8,920 new cases of Hodgkin lymphoma and 1,100 deaths in the United States, figures SEER carries rather than calculates. That is under 1 percent of all new cancers.
What separates it from non-Hodgkin lymphoma is a specific abnormal cell seen under the microscope. Classic Hodgkin lymphoma contains Reed-Sternberg cells, which usually arise from B cells, a type of white blood cell that normally makes antibodies. NCI divides classic Hodgkin lymphoma into four subtypes: nodular sclerosis, mixed cellularity, lymphocyte depleted, and lymphocyte rich. A separate and less common form is called nodular lymphocyte predominant Hodgkin lymphoma. It carries different markers on its cells, and it is treated as its own entity.
How it usually shows up
The classic opening is a painless swollen lymph node. StatPearls notes that Hodgkin lymphoma commonly begins in the cervical nodes, meaning the nodes in the neck, and often stays above the diaphragm at first. Lemieux's node was in his neck, which fits the usual pattern.
Three other symptoms carry a formal name. NCI calls them B symptoms, and it defines them precisely: "Unexplained weight loss (more than 10% of body weight in the 6 months before diagnosis). Unexplained fever with temperatures above 38°C. Drenching and recurrent night sweats."
That fever threshold is 100.4°F. NCI adds that fever and weight loss carry the most prognostic weight, while night sweats alone do not worsen the outlook. Itching without a rash is also common. StatPearls describes one odd and fairly specific clue: pain in the lymph nodes after drinking alcohol.
When to get checked
Bring these to a clinician rather than waiting them out.
- A swollen lymph node that has not shrunk after four weeks, especially if it is painless, firm, and rubbery
- Any swollen node above the collarbone, at any size and at any age
- A node that keeps getting bigger, or one larger than about an inch across
- Fever above 100.4°F with no infection to explain it, coming and going for weeks
- Night sweats that soak through nightclothes or bedding
- Losing more than a tenth of your body weight in six months without trying
- Itching all over with no rash, or node pain that starts after you drink alcohol
Most swollen nodes are infections and settle down. The point is the ones that do not.
Why the biopsy has to be the right kind
NCI's guidance for clinicians is blunt about this step: "Biopsy (preferably excisional), with interpretation by a qualified pathologist." Excisional means the whole node comes out.
StatPearls explains the reason. A pathologist has to find a Reed-Sternberg cell inside intact tissue, and fine-needle or core-needle samples are usually inadequate for that. A needle test that comes back inconclusive is a common reason a diagnosis gets delayed.
Staging asks where, not how bad
Staging maps how far the disease has spread. NCI states that "PET scans combined with CT scans have become the standard imaging for clinical staging." A PET scan uses a radioactive sugar tracer that lights up active lymphoma. CT of the neck, chest, abdomen, and pelvis is the alternative.
Stages I and II are called limited disease, and stages III and IV are advanced. A letter is attached to the number. B means the person has those B symptoms, and A means they do not.
Treatment, and the scan in the middle of it
Treatment combines chemotherapy with radiation therapy, and the mix depends on stage and on other risk features. NCI names ABVD as a common regimen. Radiation is often aimed at the involved sites rather than at broad areas of the body.
One modern refinement matters. NCI describes response-adapted treatment, in which a PET scan partway through chemotherapy is used to decide whether to intensify or ease off. The scan result changes the plan rather than merely recording it.
The outlook, and the decades after it
NCI states that "up to 90% of all newly diagnosed patients with HL can be cured with combination chemotherapy and/or radiation therapy." That is one of the strongest figures in adult oncology, and it applies to a large group rather than to any single person.
Because so many people are cured, survivorship care is a real part of this disease. NCI lists the late effects that follow treatment: second cancers, especially of the lung and breast, heart disease, infertility, an underactive thyroid, and lasting fatigue. At 40 years of follow-up, the risk of a second solid tumor reaches roughly 48 percent. That number comes from people followed for four decades, so it reflects the radiation fields and drug doses used in earlier eras.
The practical takeaway is durable. Anyone treated for Hodgkin lymphoma should stay in long-term follow-up, and should make sure a future clinician knows exactly which drugs and which radiation fields were used.
Sources
- https://www.nhl.com/news/mario-lemieux-s-return-from-hodgkins-lymphoma-on-march-2-1993-was-amaz-341674890
- https://mariolemieux.org/30-years-ago-today/
- https://www.cancer.gov/types/lymphoma/hp/adult-hodgkin-treatment-pdq
- https://www.ncbi.nlm.nih.gov/books/NBK499969/
- https://www.cancer.org/research/cancer-facts-statistics.html
- https://seer.cancer.gov/statfacts/html/hodg.html
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Hodgkin lymphoma. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.